E. Jones

发表

Angiotensin AT2 receptors: cardiovascular hope or hype?

R. Widdop, R. E. Hannan, T. Gaspari, 2003, British journal of pharmacology.

Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.

A. Christopoulos, W. Thomas, M. Aguilar, 2011, Clinical science.

Differential Mechanisms of Ang (1-7)-Mediated Vasodepressor Effect in Adult and Aged Candesartan-Treated Rats

K. Denton, R. Widdop, E. Jones, 2011, International journal of hypertension.

Direct AT₂ receptor stimulation is athero-protective and stabilizes plaque in apolipoprotein E-deficient mice.

Antony Vinh, R. Widdop, T. Gaspari, 2013, International journal of cardiology.

Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis.

R. Summers, T. Hewitson, R. Widdop, 2014, Kidney international.

Renal functional effects of the highly selective AT2R agonist, β-Pro7 Ang III, in normotensive rats

R. Carey, M. Aguilar, M. D. Del Borgo, 2020, Clinical science.

Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.

M. Black, R. Widdop, E. Jones, 2004, Journal of molecular and cellular cardiology.

Serelaxin and the AT2 Receptor Agonist CGP42112 Evoked a Similar, Nonadditive, Cardiac Antifibrotic Effect in High Salt-Fed Mice That Were Refractory to Candesartan Cilexetil.

K. Denton, Yan Wang, R. Widdop, 2020, ACS pharmacology & translational science.

Effect of dietary supplementation with b -casein A1 or A2 on markers of disease development in individuals at high risk of cardiovascular disease

A. Dart, B. Kingwell, J. Shennan, 2006 .

Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivo

T. Arumugam, C. Sobey, Hyun Ah Kim, 2012, Experimental & Translational Stroke Medicine.

Update on the Angiotensin AT2 Receptor

K. Denton, R. Widdop, Claudia A. McCarthy, 2013, Current Hypertension Reports.

Sex Differences in the Pressor and Tubuloglomerular Feedback Response to Angiotensin II

Russell D. Brown, K. Denton, L. Hilliard, 2012, Hypertension.

Non-peptide AT2-receptor agonists.

A. Hallberg, B. Dahlöf, T. Unger, 2011, Current opinion in pharmacology.

Influence of Angiotensin II Subtype 2 Receptor (AT2R) Antagonist, PD123319, on Cardiovascular Remodelling of Aged Spontaneously Hypertensive Rats during Chronic Angiotensin II Subtype 1 Receptor (AT1R) Blockade

M. Black, R. Widdop, E. Jones, 2012, International journal of hypertension.

VASCULAR ANGIOTENSIN AT2 RECEPTORS IN HYPERTENSION AND AGEING

D. Henrion, Antony Vinh, R. Widdop, 2008, Clinical and experimental pharmacology & physiology.

β-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive rats.

P. Perlmutter, M. Aguilar, M. D. Del Borgo, 2015, Clinical science.

Sex-Specific Influence of Angiotensin Type 2 Receptor Stimulation on Renal Function: A Novel Therapeutic Target for Hypertension

T. Unger, K. Denton, U. Steckelings, 2012, HYPERTENSION.

A Single &bgr;-Amino Acid Substitution to Angiotensin II Confers AT2 Receptor Selectivity and Vascular Function

P. Perlmutter, W. Thomas, M. Aguilar, 2011, Hypertension.

CHBPR 164301 : A SINGLE BETA-AMINO ACID SUBSTITUTION TO ANGIOTENSIN II CONFERS AT 2 RECEPTOR SELECTIVITY AND VASCULAR FUNCTION

P. Perlmutter, M. Aguilar, D. Clayton, 2011 .

Stimulation of angiotensin AT2 receptors by the non‐peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats

A. Hallberg, R. Widdop, E. Jones, 2010, British journal of pharmacology.

Enhanced Angiotensin II Type 2 Receptor Mechanisms Mediate Decreases in Arterial Pressure Attributable to Chronic Low-Dose Angiotensin II in Female Rats

K. Denton, Amanda K. Sampson, K. Moritz, 2008, Hypertension.

and Dysfunction : Contribution to Hypertension and EndothelialSLC 7 A 1 Transporter Gene Identification of a Novel Polymorphism in the 3 ' UTR of the L-Arginine

B. Morris, D. Kaye, J. Chin-Dusting, 2007 .

Ganging up on angiotensin II type 1 receptors in vascular remodeling.

Antony Vinh, R. Widdop, T. Gaspari, 2012, Hypertension.

Post-Stroke Inhibition of Induced NADPH Oxidase Type 4 Prevents Oxidative Stress and Neurodegeneration

H. Fuchs, A. Shah, N. Weissmann, 2010, PLoS biology.

Reversal of Vascular Macrophage Accumulation and Hypertension by a CCR2 Antagonist in Deoxycorticosterone/Salt-Treated Mice

J. Armitage, C. Sobey, Antony Vinh, 2012, Hypertension.

AT2 receptors: Functional relevance in cardiovascular disease

Antony Vinh, R. Widdop, Antony Vinh, 2008, Pharmacology & Therapeutics.

Identification of a Novel Polymorphism in the 3′UTR of the l-Arginine Transporter Gene SLC7A1: Contribution to Hypertension and Endothelial Dysfunction

B. Morris, D. Kaye, J. Chin-Dusting, 2007, Circulation.

Reduced cardiovascular reactivity to stress but not feeding in renin enhancer knockout mice.

B. Morris, J. Chin-Dusting, G. Head, 2007, American journal of hypertension.

Electronic Sculpting of Ligand-GPCR Subtype Selectivity: The Case of Angiotensin II

T. Crook, J. Selent, M. Tamura, 2014, ACS chemical biology.

Chapter 19 – Angiotensin-Based Peptides as AT2R Agonists

M. Aguilar, K. Denton, Yan Wang, 2015 .

AT2R, vascular effects, and blood pressure

M. Aguilar, Antony Vinh, K. Denton, 2015 .

Response to Can the Study of Female Rats Help Our Understanding of Women

K. Denton, Amanda K. Sampson, K. Moritz, 2008 .

Cardioprotective effects in aged spontaneously hypertensive rats due to chronic stimulation/activation of sGC without hypotension

J. Stasch, H. Schmidt, R. Widdop, 2009, BMC Pharmacology.

Reversal of Vascular Macrophage Accumulation and Hypertension by a CCR2 Antagonist in Deoxycorticosterone/Salt-Treated Mice

J. Armitage, C. Sobey, Antony Vinh, 2012, Hypertension.

Sex Differences in the Pressor and Tubuloglomerular Feedback Response to Angiotensin II

Russell D. Brown, K. Denton, L. Hilliard, 2012, Hypertension.